Dysfunction of HLA-B27

References

• Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137–42
   PubMedGoogle Scholar
• Spies T, Bresnahan M, Strominger JL. Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. PNAS USA 1989; 86: 8955–8
   PubMed Web of Science ®Google Scholar
• Jacob C O, Fronek Z, Lewis G D, Koo M, Hansen J A, McDevitt HO. Heritable major histocompatibility complex Class II associated differences in production of tumor necrosis factor alfa: relevance to genetic predisposition to systematic lupus erythematosus. PNAS USA 1990; 87: 1233–7
   PubMed Web of Science ®Google Scholar
• Zervas J, Valassi-Adam H, Konstantopoulos K. HLA subtypes and meningococcal disease. Lancet 1989; ii: 869
   Google Scholar
• Gattaz W F, Bechmann H. HLA antigens and schizophrenia. Lancet 1980; i: 98–9
   Google Scholar
• Ivanyi P. Polymorphism du CMH et Evolution. HLA complexe majeur d'histocompatibilite de l'homme, J Dausset, M Pla. Flammarion, Paris 1989; 233–52
   Google Scholar
• Balner H. Genetic considerations. The major histocompatibility complex of primates: evolutionary aspects and comparative histogenetics. Phil Trans R Soc Lond B 1981; 292: 109
   Google Scholar
• Mayer W, Jonker M, Klein D, Ivanyi P, van Seventer G, Klein J. Nucleotide sequences of chimpanzee MHC Class 1 alleles: evidence for trans-species mode of evolution. EMBO J 1988; 7: 2765–74
   PubMedGoogle Scholar
• Klein J. Origin of MHC polymorphism: the trans-species hypothesis. Hum Immunol 1987; 19: 155
   PubMed Web of Science ®Google Scholar
• Ivanyi P. Interspecies MHS relationships studied by serological and cellular cross-reactions. Current trends in histocompatibility. Vol. 1, R. A. Reisfeld, S. Ferrone. Plenum Publ. 1981; 133–81
   Google Scholar
• de Lopez Castro. HLA-B 27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 1989; 10: 239–46
   Google Scholar
• Breur-Vriesendorp B S, De Waal L P, Ivanyi P. Different linkage disequilibria of HLA-B 27 subtypes and HLA-C locus alleles. Tissue Antigens 1988; 32: 74–77
   Google Scholar
• Breuning M H, Lucas C J, Breur B S, Engelsma M Y, De Lange G G, Dekker A J, Biddison W E, Ivanyi P. Stubtypes of HLA-B 27 detected by cytotoxic T lymphocytes and their role in self-recognition. Hum Immunol 1982; 5: 259–68
   Google Scholar
• Grumet F C, Fendly B M, Fish L, Foung S, Engleman EG. Monoclonal antibody (B27M2) subdividing HLA-B 27. Hum Immunol 1982; 5: 61–72
   PubMed Web of Science ®Google Scholar
• Choo S Y, Antonelli P, Nisperos B, Nepom G T, Hansen J A. Six variants of HLA-B 27 identified by isoelectric focusing. Immunogenetics 1986; 23: 24–29
   PubMed Web of Science ®Google Scholar
• Neefjes J J, Breur-Vriesendorp B S, van Seventer G A, Ivanyi P, Ploegh HG. An improved biochemical method for the analysis of polymorphism of HLA class I antigens. Definition of new HLA class I subtypes. Hum Immunol 1986; 16: 169–81
   PubMed Web of Science ®Google Scholar
• De Waal L P, Krom F EJM, Breur-Vriesendorp B S, Engelfriet C P, Lopez, de Castro J A, Ivanyi P. Conventional alloantisera can recognize the same HLA-B 27 polymorphism as detected by cytotoxic T lymphocytes. Hum Immunol 1988; 20: 265–71
   Google Scholar
• Grumet F C, Calin A, Engleman E G, Fish L, Found S KH. Studies of HLA-B 27 using monoclonsal antibodies: ethnic and disease associated variants. Advances in inflammation research. Vol. 9. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 41–53
   Google Scholar
• Breur-Vriesendorp B S, Dekker-Saeys A J, Ivanyi P. Distribution of HLA-B 27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheumat Dis 1987; 46: 353–56
   PubMedGoogle Scholar
• Derhaag P JFM, Rothova A, Linssen A, Feltkamp T EW. Acuter anterioir uveitis and HLA-B 27. Internat. Ophthalmol, in Press
   Google Scholar
• Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, Merilahti-Palo R, Saario R, Isomaki H, Roivanen A. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. New Engl J Med 1989; 320: 216–21
   PubMed Web of Science ®Google Scholar
• Granfors K, Jalkanen S, Lindberg A A, Maki-Ikola O, von Essen R, Lahesmaa-Rantala R, Isomaki H, Saario R, Arnold W J, Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685–88
   PubMed Web of Science ®Google Scholar
• Toubert A, Gomard E, Grumet F C, Amor B, Miller J Y, Levy JP. Identification of several functional subgroups of HLA-B 27 by restriction of the activity of antiviral T killer lymphocytes. Immunogenetics 1984; 20: 513–25
   Google Scholar
• Kievits F, Ivanyi P, Krimpenfort P, Berns A, Ploegh HL. HLA restricted recognition of viral antigens in HLA transgenic mice. Nature 1987; 329: 447–49
   PubMed Web of Science ®Google Scholar
• Kievits F, Wijffels J, Lokhorst W, Boerenkamp W J, Ivanyi P. HLA expression and function in single and double HLA-transgenic mice. Tissue antigens 1989; 34: 50–63
   Google Scholar
• Kievits F, Wijffels J, Lokhorst W, Boerenkamp W J, Ivanyi P. H-2 restricted recognition of xeno-MHC antigens by primary mouse cytotoxic T cells is the exception rather than the rule. Transgenic mice and mutants in MHC research, I Egorov, C David. Springer-Verlag, Heidelberg 1989, in press
   Google Scholar
• Ebringer A, Baines M, Childerstone M, Ghuloom M. Ptaszynska: Etiopathogenesis of ankylosing spondylitis and the cross-tolerance hypothesis. Advances in inflammation research. Vol. 9. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 101–28
   Google Scholar
• Ebringer A, Colthorpe D, Young A, Corbett M. Increased incidence of faecal Klebsiella penumoniae in patients with HLA-B 7 CREG antigen and men with rheumatoid arthritis. Br Med J 1980; 583–5
   Google Scholar
• Kinsella TG. Review of research on the role of Klebsiella antigens in the spondylarthropathies. Advances in inflammation research. Vol. 9. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 139–149
   Google Scholar
• Brewerton DA. Ankylosing spondylitis and acute anterior uveitis: a quest for infective agents. Advances in inflammation research. Vol. 9. The spondylarthropathies, M Ziff, SB Cohen. Raven Press, New York 1985; 151–5
   Google Scholar
• Trull A, Ebringer A, Panayi G, Ebringer R, James D CO. HLA-B 27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984; 55: 74–80
   PubMed Web of Science ®Google Scholar
• Landsteiner K. The specificity of serological reactions.Rev. ed. Dover, New York 1962
   Google Scholar
• van Regenmortel M HV. Which structural features of antigens do antibodies recognize. Immunogenicity of protein antigens, E E Sercarz, J A Berzofsky. CRC Press, Boca Raton, Florida 1987
   Google Scholar
• Srinivasappa J, Saegusa J, Prabhakar B S, Gentry M K, Buchmeier M J, Wiktor T J, Koprowski H, Oldstone M BA, Notkins AL. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986; 57: 397–401
   PubMed Web of Science ®Google Scholar
• Maeda K, Kono D, Kobayashi S, Brenner M B, Yu D TY. A study of the specificity of the direct binding between bacteria and HLA antigens. Clin Exp Immunol 1984; 57: 694–702
   Google Scholar
• Ivanyi P. Interspecies MHS relationships studied by serological and cellular cross-reactions. Current trends in histocompatibility. Vol I, RA Reisfeld, S Ferrone. Plenum Publishing Corp, New York 1981; 133–81
   Google Scholar
• Mittal K K, Terasaki P I, Springer G F, Dessai P R, McLntire F C, Hirata AA. Inhibition of anti-HLA alloantisera by glycoproteins, polysaccharides and lipopolysaccharides from divers sources. Transpl Proc 1973; 5: 499–506
   PubMedGoogle Scholar
• Ratschko K W, Stamm H, Westphal E. Muller-Ruchlotz: Search for HL-A antigenic determinants in bacteria and rodents. Z Immunitaetsforsch 1975; 148: 407–10
   Google Scholar
• Ren M N, Zhang J J, Nakyama A, Yu D TY. Reactivity between monoclonal anti-HLA-B27 antibodies and bacterial components: is there a consensus of findings?. Rheumatol Int 1989; 9: 219–21
   Google Scholar
• van Bohemen C G, Grumet F C, Zanen HC. HLA-B 27M1 and M2 cross-reactive enterobacterial antigens. Advances in inflammation research. Vol. 9. The spondyloarthropathies, M Ziff, SB Cohen. Raven Press, New York 1985; 157–64
   Google Scholar
• Ogasawara M, Kono D H, Yu D TY. Mimicry of human histocompatibility HLA-B 27 antigens by Klebsiella pneumoniae. Infect Immun 1986; 51: 901–8
   PubMed Web of Science ®Google Scholar
• Welsh J, Avakian H, Cowling P, Ebringer A, Wooley P, Panayi G, Ebringer R. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol 1980; 61: 85–91
   PubMedGoogle Scholar
• Avakian H, Welsh J, Ebringer A, Entwistle CC. Ankylosing spondylitis, HLA-B 27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol 1980; 61: 92–6
   PubMedGoogle Scholar
• Raybourne R R, Bunning V K, Williams KM. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. J Immunol 1988; 140: 3489–95
   PubMed Web of Science ®Google Scholar
• Chen J H, Kono D H, Yong Z, Park M S, Oldstone M MBA, Yu D TY. A yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol 1987; 139: 3003–11
   PubMed Web of Science ®Google Scholar
• Yong Z, Zhang J J, Schaack T, Chen S, Nakayama A, Yu D TY. A monoclonal anti-HLA-B27 antibody which is reactive with a linear sequence of the HLA-B 27 protein is useful for the study of molecular mimicry. Clin Exptl Rheumatol 1989; 7: 513–9
   Google Scholar
• Tongio M M, Mitsuishi Y, Urlacher A, Mayer S. Naturally occurring HLA antibodies. MHC+X, P Ivanyi. Springer Verlag, Heidelberg 1987; 18–22
   Google Scholar
• Cavender D, Ziff M. Anti-HLA-B27 antibodies in sera from patients with gram-negative bacterial infections. Arthritis Rheum 1986; 29: 352–7
   Google Scholar
• Kono D H, Ogasawara M, Effros R B, Park M S, Walford R L, Yu D TY. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria. Clin Exp Immunol 1985; 61: 503–8
   PubMed Web of Science ®Google Scholar
• Yu D TY. Molecular mimicry in HLA-B27-related arthritis. Ann Intern Med 1989; 111: 581–91
   PubMed Web of Science ®Google Scholar
• Kievits F, Rocca A, Limpens J, Leupers T, Kloosterman T, Boerenkamp W I, Pla M, Ivanyi P. Induction of H-2 specific antibodies by injection of syngeneic Sendai virus-coated cells. Eur J Immunol 1987; 17: 27–35
   Google Scholar
• Cerny-Provaznik R, Kloosterman T, Verkerk D, van Mourik P, Reboul M, Frangoulis B, Pla M, Ivanyi P. Anti-MHC immunity detected prior to intentional alloimmunization. IV. Natural monoclonal H-2-specific antibodies. J Immunogenetics 1986; 13: 287–97
   Google Scholar
• Oldstone M BA. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819–20
   PubMed Web of Science ®Google Scholar
• Schwimmeck P L, Oldstone M BA. Molecular mimicry between human leukocyte antigen B 27 and Klebsiella. Consequences for spondyloarthropathies. Am J Med 1988; 85: 51–3, Suppl 6A
   Google Scholar
• Russel AS. Molecular mimicry—a chimera?. J Rheumatol 1989; 16: 1528–9
   Google Scholar
• Oldstone M AA, Whitton J L, Lewicki H, Tishon A. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class 1 restricted H-2Db cytotoxic T lymphocyte. JEM 1988; 168: 559–70
   Google Scholar
• Schwimmbeck P L, Yu D TY, Oldstone M BA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. JEM 1987; 166: 173–81
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P L, Oldstone M BA. Autoimmune pathogenesis for ankylosing spondylitis (AS) and Reiter's syndrome (RS): autoantibodies against an epitope shared by HLA B27 and Klebsiella pneumoniae nitrogenase in sera of HLA B27 patients with AS and RS. Trans Assoc Am Phys 1987; 100(6)28–39
   Google Scholar
• Tsuchiya N, Husby G, Williams RC. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol 1989; 76: 354–60
   PubMed Web of Science ®Google Scholar
• Conger J D, Pike B L, Nossal G JV. Analysis of the B lymphocyte repertoire by polyclonal activation. Hindrance by clones yielding antibodies which bind promiscuously to plastic. J Immunol Meth 1988; 106: 181–9
   Google Scholar
• Ewing C, Ebringer R, Tribbick G, Geysen HM. Antibody activity in ankylosing spondylitis sera to two sites of HLA-B 27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). JEM 1990; 171: 1635–47
   PubMed Web of Science ®Google Scholar
• Laver WG, Air GM, Webster RG, Smith-Gill SJ. Epitopes on protein antigens: misconceptions and realities. Cell 1990; 61: 553–6
   PubMed Web of Science ®Google Scholar
• Cavender D E, Ziff M. Absence of anti-enterobacteriaceae and anti-HLA-B27 antibodies in mitogen stimulated cultures of lymphocytes from patients with Reiter's syndrome and ankylosing spondylitis. J Rheumatol 1988; 15: 315–20
   PubMedGoogle Scholar
• Geczy A F, Alexander K, Bashir HV. A factor (s) in Klebsiella culture filtrates specifically modifies an HLA-B 27-associated cell surface component. Nature 1980; 283: 782–4
   PubMed Web of Science ®Google Scholar
• Druery C, Bashir H V, Geczy A F, Alexander K, Edmonds J. Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27+AS+ individuals. Human Immunol 1980; 1: 151–60
   PubMed Web of Science ®Google Scholar
• Edmonds J, Macauley D, Tyndall A, Liew M, Alexander K, Geczy A, Bashir H. Lymphocyto-toxicity of anti-Klebsiella antisera in ankylosing spondylitis and related arthropathies. Arthritis 1981; 24: 1–7
   Google Scholar
• Orban P, Sullivan J S, Geczy A F, Upfold L I, Coulits N, Bashir HV. A factor shed by lymphoblastoid cell lines of HLA-B 27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals. Clin Exp Immunol 1983; 53: 10–16
   Google Scholar
• Prendergast J K, Sullivan J S, Geczy A F, Upfold L I, Edmonds J P, Bashir HV. The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary. Human Immunol 1984; 9: 131–6
   PubMedGoogle Scholar
• Upfold L I, Sullivan J S, Prendergast J K, Geczy AF. HLA-B 27: speculation on the nature of its involvement in ankylosing spondylitis. Prog Allergy 1985; 36: 177–89
   PubMedGoogle Scholar
• Geczy A F, Prendergast J K, Sullivan J S, Upfold L I, Edmonds J P, Bashir HV. Possible role of enteric organisms in the pathogenesis of the seronegative arthropathies. Advances in inflammation research. Vol. 9. The spondyloarthropathies, M Ziff, S B Cohen. Raven Press, New York 1985; 129–37
   Google Scholar
• Geczy A FMC, Guigan L E, Sullivan J S, Edmonds JP. Cytotoxic T lymphocytes against disease associated determinant(s) in ankylosing spondylitis. J Exp Med 1986; 164: 932–937
   PubMed Web of Science ®Google Scholar
• Archer JR. Search for cross-reactivity between HLA B27 and Klebsiella pneumoniae. Ann Rheumat Dis 1981; 40: 400–3
   PubMed Web of Science ®Google Scholar
• Singh B, Milton J D, Woodrow JC. Ankylosing spondylitis, HLA-B27, klebsiella: a study of lymphocyte reactivity of anti-klebsiella sera. Ann Rheumat Dis 1986; 45: 190–7
   PubMedGoogle Scholar
• van Leewen A, van Bree F PMJ, Beukelman C J, van Rood JJ. Antisera to “modifying factor” in patients with ankylosing spondylitis: the present situation. MHC+X, P Ivanyi. Springer-Verlag, Heidelberg 1987; 30–33
   Google Scholar
• Beukelman C J, van Leeuwen A, Aerts P C, van Kregten E, van Bree S, van Rood J J, Willers J MN, van Dijk H. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for mononuclear cells of AS-patients. Br J Rheumatol 1988; 27: 58–60, Suppl II
   Google Scholar
• Moving V, Sparck JV. The relationship between klebsiella antigens and human HLA-B27 tissue type antigens in ankylosing spondylitis. Sixth International Congress Immunol. Toronto 1986, Abstract No. 5.11.29.
   Google Scholar
• Archer J R, Stubbs M M, Currey H LF, Geczy AF. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population. Lancet 1985; i: 344–5
   Google Scholar
• Archer J R, Stubbs M M, Geczy AF. Factors influencing the cytotoxicity of anti-bacterial sera from lymphocytes from ankylosing spondylitis patients. Clin Exptl Rheumatol 1988; 6: 35–9
   PubMedGoogle Scholar
• van Rood J J, van Leeuwen A, Ivanyi P, Cats A, Breur-Vriesendorp B S, Dekker-Saeys A J, Kijlstra A, van Kregten E. Blind confirmation of Geczy factor in ankylosing spondylitis. Lancet 1985; 2: 943–4
   Google Scholar
• Geczy A F, van Leewen A, van Rood J J, Ivanyi P, Breur-Vriesendorp B S, Cats A. Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitis. Human Immunol 1986; 17: 239–45
   Google Scholar
• Breur-Vriesendorp B S, Post F A, De Waal L P, Blokland W, Pool J, van der Linden S, Dekker-Saeys B J, Goulmy E, Ivanyi P. Blood lymphocytes from ankylosing spondylitis patient fail to induce disease-specific cytotoxic T lymphocytes. Human Immunology 1989; 25: 149–55
   PubMed Web of Science ®Google Scholar
• Husby G, Tsuchiya N, Schwimmbeck P L, Keat A, Pahle J A, Oldstone M BA, Williams R. Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B 27+ patients with ankylosing spondylitis. Arthritis Rheum 1989; 32: 437–45
   PubMed Web of Science ®Google Scholar
• Abi-Hanna D, Wakefield D. Differential enhancement of HLA-B 27 by interferon. Human Immunol 1990; 27: 33–9
   Google Scholar
• Schmidt H, Gekeler V, Engler B, Ium G, Steiert I, Probst H, Muller CA. Differential regulation of HLA class I genes by interferon. Immunogenetics 1990; 31: 245–52
   PubMedGoogle Scholar
• Leirisalo M, Repo H, Tilikainen A, Kosunen T U, Laitinen O. Chemotaxis in Yersinia arthritis. HLA-B 27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum 1980; 23: 1936–044
   Google Scholar
• Feltelius N, Lindh U, Venge P, Hallgren R. Ankylosing spondylitis: a chronic inflammatory disease with iron overload in granulocytes and platelets. Ann Rheumatol Dis 1986; 45: 827–31
   Google Scholar
• Pla M, Rocca A. Fonctions non immunologiques assoctées au CMH. HLA complexe majeur d'histocompatibilite' de l'homme, J Dausset, M Pla. Flammarion, Paris 1989; 233–52
   Google Scholar
• Archer J R, Badakere S S, McLean IL. Post-translational heterogeneity of HLA-B 27: a new hypothesis for its role in inflammation. Br J Rheumatol 1989; 28: 143, Abstract
   PubMedGoogle Scholar
• Plomann M, Schwochau M, Ch Specker, Lakomek HJ. Ankylosing spondylitis—an autoimmune disease after all?. Br J Rheumatol 1989; 28: 168, Abstract
   Google Scholar
• Curry R, Thoen J, Ch Shelborne, Gaudernack G, Messner R. Antibodies to and elevation of beta2 microglobulin in the serum of ankylosing spondylitis patients. Arthritis Rheum 1982; 25: 375–80
   PubMedGoogle Scholar
• Sweet H O, Green MC. Progressive ankylosis, a new skeletal mutation in the mouse. J Hered 1981; 72: 87–93
   PubMedGoogle Scholar
• Hakim F T, Cranley R, Brown K S, Eannes E D, Harne L, Oppenheim J JH. Hereditary joint disorders in progressive ankylosing (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy. Arthr Rheumat 1984; 27: 1411–20
   Google Scholar
• Sampson HW. Spondylarthropathy in progressive ankylosing (and/ank) mice: morphological features. Spine 1988; 13: 645–49
   Google Scholar
• Sampson H W, Davis JS. Histopathology of the intervertebral disc of progressive ankylosis mice. 1988; 13: 650–54
   Google Scholar
• Mahowald M L, Krug H, Taurog J. Progressive ankylosis in mice. An animal model of spondylarthropathy. I. Clinical and radiographic findings. Arthr Rheumat 1988; 31: 1390–99
   PubMed Web of Science ®Google Scholar
• Mahowald M L, Krug H, Halverson P. Progressive ankylosis (ank/ank) in mice: an animal model of spondylarthropathy. II. Light and electron microscopic findings. J Rheumatol 1989; 16: 60–66
   Google Scholar
• Hill J L, Yu TY. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infection Immunity 1987; 55: 721–26
   PubMed Web of Science ®Google Scholar
• Yong Z, Hill J L, Hirofuji T, Mander M, Yu D TY. An experimental mouse model of Yersinia induced reactive arthritis. Microbial Pathogenesis 1988; 4: 305–10
   Google Scholar
• Binder A, Gartner K, Hendrich H J, Hermans W, Kirchoff H, Wonigeit K. Strain differences in sensitivity of rats to Mycoplasma arthritidis ISR 1 infection are under multiple gene control. Infection Immunity 1990; 58: 1584–90
   Google Scholar
• Cole B C, Piepkorn M W, Wright BS. Influence of genes of the major histocompatibility complex on ulcerative dermal necrosis induced in mice by Mycoplasma arthritidis. J Invest Dermatol 1985; 85: 347–61
   Google Scholar
• Chapdelaine J M, Whalen J D, Seibold J R, Wooley PH. Pristane-induced arthritis in mice: genetic regulation and immunity in an experimental model of arthritis. H-2 antigens, genes, molecules, function. NATO Series A: Life sciences, vol. 144, Ch. S David. Plenum Press, London, New York 1987; 779–88
   Google Scholar
• Banerjee S, Haqqi T M, Luthra H S, David Ch. S. Role of MHC genes and T cell receptor genes in collagen induced arthritis in mice. H-2 antigens, genes, molecules, function. NATO Series A: Life sciences, vol. 144, Ch. S David. Plenum Press, London, New York 1987; 779–88
   Google Scholar
• Krimpenfort P, Rudenko G, Hochstenbach F, Guessow D, Berns A, Ploegh H. Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (beta-2-microglobulin) chains of HLA Class I antigens. EMBO J 1987; 6: 1673–76
   PubMedGoogle Scholar
• Kievits F, Wijffels J, Lokhorst W, Ivanyi P. Recognition of xeno-(HLA, SLA)-MHC antigens by mouse cytotoxic T cells is not H-2-restricted. A study with transgenic mice. Proc Natl Acad Sci USA 1989; 86: 617
   PubMed Web of Science ®Google Scholar
• Kievits F, Boerenkamp W J, Lokhorst W, Ivanyi P. Specificity and frequency on anti-HLA primary cytotoxic T lymphocytes in normal and HLA-B27.2, HLA-B27.5 and HLA-Cw3 transgenic mice. A transgenic model for MHC-xenoantigen recognition. J Immunol 1990, In press
   Google Scholar
• Kievits F, Lokhorst W, Ivanyi P. Abnormal anti-viral immune response in mice is corrected by germline therapy with a human Class I (HLA-B27) gene. Europ J Immunol 1990; 20: 1189–92
   Google Scholar
• Pla M, Samaan A, Gillet D, Reboul M, Frangoulis B, Opolski A, Chopin M, Degos L. Human HLA-B27 antigen in transgenic mice can function as a major histocompatibility antigen. Transgenic mice and mutants in MHC research, I K Egorov, C S David. Springer-Verlag, Berlin 1990; 173–78
   Google Scholar
• Taurog J D, Lowen L, Forman J, Hammer RE. HLA-B27 in inbred and non-inbred transgenic mice. J Immunol 1988; 141: 4020–3
   Google Scholar
• Luthra H S, Nickerson C L, Savarirayan S, David CS. HLA-B27 and Arthritis. Transgenic mice and mutant in MHC research, I K Egorov, C S David. Springer-Verlag, Berlin 1990; 268–75
   Google Scholar
• Carter P B, Collins FM. Experimental Yersinia enterocolitica infection in mice: kinetics of growth. Infect Immun 1974; 9: 851–7
   PubMed Web of Science ®Google Scholar
• Hancock G E, Schaedler R W, MacDonald TT. Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect Immun 1986; 53: 26–31
   PubMedGoogle Scholar
• Taurog J D, Hammer R E, Maika S D, Sams K L, El-Zatari F AK, Stimpson S A, Schwab JH. HLA-B27 transgenic mice as potential models of human disease. Transgenic mice and mutants in MHC research, I K Egorov, C S David. Springer-Verlag, Berlin 1990; 268–75
   Google Scholar
• Derhaag PJFM, Baas E J, Feltkamp T EW, Ploegh HL. HLA-B27 and b2m double transgenic mice as a model for HLA-B27 associated diseases. Doctoral Thesis, University of Amsterdam. 1989
   Google Scholar
• Huet S, Nixon D F, Rothbard J B, Townsend A, Ellis S, McMichael AJ. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA-B27. Int Immunol 1990; 2: 311–6
   Google Scholar
• Oksenberg J R, Sherrit M, Begovich A B, Erlich H A, Bernard C CA, Cavalli-Sforza L L, Stein-Man L. T cell receptor V-alfa and C-alfa alleles associated with multiple sclerosis and myasthenia gravis. PNAS 1989; 86: 988–92
   PubMed Web of Science ®Google Scholar
• Oksenberg J R, Stuart S, Begovich A B, Bell R B, Erlich H A, Steinman L, Bernard C CA. Limited heterogeneity of rearranged T cell receptor Valfa transcripts in brains of multiple sclerosis patients. Nature 1990; 345: 344–6
   PubMed Web of Science ®Google Scholar
• Breur-Vriesendorp B S, Vingerhoed J, van Twuyver E, De Waal L P, Ivanyi P. Frequency analysis of HLA-specific cytotoxic T-lymphocyte precursors in humans. Transplantation 1990, submitted
   Google Scholar
• Gomard E, Sitbon M, Toubert A, Begue B, Levy JP. HLA-B27, a dominant restricting element in antiviral responses?. Immunogenetics 1984; 20: 197–204
   Google Scholar
• Silverman D H, Sayegh M H, Alvarez C E, Johnson T S, Milford E L, Karnovsky ML. HLA Class II restricted binding of muramyl peptides to B lymphocytes of normal and narcoleptic subjects. Human Immunol 1990; 27: 145–54
   Google Scholar